Werbung
Werbung
Vereinigte Staaten von Amerika Aktien
Führende Pharmazeutika Industrie
Siehe:
Übersicht
Leistung
50 Ergebnisse
| Ticker | Name | Letzter | Änderung | Veränderung (%) | Volumen | Markt Cap | KGV | EPS | Sektor | Branche |
|---|---|---|---|---|---|---|---|---|---|---|
| LLY | Lilly(Eli) & Co | $770.86 | -0.26 | -0.03% | 77,864 | 732.63B | 105.92 | 6.79 | Gesundheitstechnologie | Führende Pharmazeutika |
| JNJ | Johnson & Johnson | $154.65 | 0.37 | 0.24% | 223.90K | 372.19B | 14.75 | 16.04 | Gesundheitstechnologie | Führende Pharmazeutika |
| MRK | Merck & Co Inc | $131.20 | 0.32 | 0.24% | 185.04K | 332.30B | 60.31 | 0.90 | Gesundheitstechnologie | Führende Pharmazeutika |
| ABBV | Abbvie Inc | $166.48 | 2.13 | 1.30% | 204.80K | 293.98B | 14.99 | 3.37 | Gesundheitstechnologie | Führende Pharmazeutika |
| AMGN | AMGEN Inc. | $312.53 | -2.19 | -0.70% | 110.42K | 167.65B | 16.89 | 7.00 | Gesundheitstechnologie | Führende Pharmazeutika |
| PFE | Pfizer Inc. | $28.65 | -0.27 | -0.93% | 750.63K | 162.35B | 20.37 | -0.06 | Gesundheitstechnologie | Führende Pharmazeutika |
| VRTX | Vertex Pharmaceuticals, Inc. | $445.23 | 4.59 | 1.04% | 58,214 | 114.89B | 29.26 | 15.41 | Gesundheitstechnologie | Führende Pharmazeutika |
| REGN | Regeneron Pharmaceuticals, Inc. | $982.77 | 14.79 | 1.53% | 16,442 | 108.29B | 26.08 | 33.85 | Gesundheitstechnologie | Führende Pharmazeutika |
| BMY | Bristol-Myers Squibb Co. | $44.04 | -0.07 | -0.16% | 608.19K | 89.27B | 42.01 | -3.10 | Gesundheitstechnologie | Führende Pharmazeutika |
| ZTS | Zoetis Inc - Class A | $173.99 | 0.28 | 0.16% | 70,397 | 79.26B | 32.23 | 5.19 | Gesundheitstechnologie | Führende Pharmazeutika |
| BIIB | Biogen Inc | $230.64 | 0.60 | 0.26% | 49,464 | 33.58B | 15.34 | 8.01 | Gesundheitstechnologie | Führende Pharmazeutika |
| ALNY | Alnylam Pharmaceuticals Inc | $149.43 | -1.79 | -1.18% | 11,327 | 18.90B | N/A | -2.68 | Gesundheitstechnologie | Führende Pharmazeutika |
| RPRX | Royalty Pharma plc - Class A | $27.25 | -0.63 | -2.26% | 74,821 | 16.66B | 7.40 | 1.34 | Gesundheitstechnologie | Führende Pharmazeutika |
| NBIX | Neurocrine Biosciences, Inc. | $142.29 | 0.38 | 0.27% | 22,135 | 14.32B | 39.09 | 3.63 | Gesundheitstechnologie | Führende Pharmazeutika |
| VTRS | Viatris Inc | $10.97 | -0.05 | -0.45% | 216.83K | 13.06B | 3.92 | -0.06 | Gesundheitstechnologie | Führende Pharmazeutika |
| INCY | Incyte Corp. | $57.12 | 0.26 | 0.46% | 98,804 | 12.83B | 19.74 | 3.30 | Gesundheitstechnologie | Führende Pharmazeutika |
| SRPT | Sarepta Therapeutics Inc | $131.47 | -1.27 | -0.96% | 46,736 | 12.43B | 1,106.17 | 0.11 | Gesundheitstechnologie | Führende Pharmazeutika |
| UTHR | United Therapeutics Corp | $274.40 | 2.18 | 0.80% | 18,732 | 12.17B | 12.87 | 21.15 | Gesundheitstechnologie | Führende Pharmazeutika |
| CTLT | Catalent Inc. | $55.37 | 0.12 | 0.22% | 27,991 | 10.02B | N/A | -6.10 | Gesundheitstechnologie | Führende Pharmazeutika |
| RGEN | Repligen Corp. | $171.93 | 0.90 | 0.53% | 15,817 | 9.61B | 124.84 | 0.25 | Gesundheitstechnologie | Führende Pharmazeutika |
| ROIV | Roivant Sciences Ltd | $11.22 | -0.18 | -1.62% | 233.16K | 9.05B | N/A | 5.20 | Gesundheitstechnologie | Führende Pharmazeutika |
| CERE | Cerevel Therapeutics Holdings Inc | $42.11 | -0.24 | -0.57% | 35,673 | 7.67B | N/A | N/A | Gesundheitstechnologie | Führende Pharmazeutika |
| VKTX | Viking Therapeutics Inc | $66.99 | -2.07 | -3.00% | 237.67K | 7.39B | N/A | -0.93 | Gesundheitstechnologie | Führende Pharmazeutika |
| JAZZ | Jazz Pharmaceuticals plc | $108.97 | -1.52 | -1.38% | 19,500 | 6.87B | 7.66 | 4.85 | Gesundheitstechnologie | Führende Pharmazeutika |
| ITCI | Intra-Cellular Therapies Inc | $65.00 | -1.53 | -2.30% | 24,390 | 6.86B | N/A | -1.16 | Gesundheitstechnologie | Führende Pharmazeutika |
| EXEL | Exelixis Inc | $20.91 | -0.32 | -1.51% | 71,037 | 6.34B | 33.17 | 0.64 | Gesundheitstechnologie | Führende Pharmazeutika |
| CYTK | Cytokinetics Inc | $59.60 | -0.32 | -0.53% | 48,974 | 6.25B | N/A | -5.40 | Gesundheitstechnologie | Führende Pharmazeutika |
| OGN | Organon & Co. | $21.80 | 0.28 | 1.30% | 64,628 | 5.61B | 5.25 | 4.09 | Gesundheitstechnologie | Führende Pharmazeutika |
| IONS | Ionis Pharmaceuticals Inc | $37.33 | -0.29 | -0.77% | 47,894 | 5.45B | N/A | -2.67 | Gesundheitstechnologie | Führende Pharmazeutika |
| IBRX | ImmunityBio Inc | $7.64 | -0.11 | -1.42% | 217.86K | 5.28B | N/A | -1.09 | Gesundheitstechnologie | Führende Pharmazeutika |
| APLS | Apellis Pharmaceuticals Inc | $41.33 | -0.67 | -1.59% | 39,732 | 5.02B | N/A | -3.46 | Gesundheitstechnologie | Führende Pharmazeutika |
| MDGL | Madrigal Pharmaceuticals Inc | $220.48 | 3.31 | 1.52% | 10,810 | 4.70B | N/A | -23.09 | Gesundheitstechnologie | Führende Pharmazeutika |
| ALKS | Alkermes plc | $24.17 | -0.29 | -1.19% | 72,029 | 4.09B | 16.20 | 2.53 | Gesundheitstechnologie | Führende Pharmazeutika |
| PRGO | Perrigo Company plc | $29.83 | -0.27 | -0.90% | 77,547 | 4.07B | 12.44 | -0.07 | Gesundheitstechnologie | Führende Pharmazeutika |
| CRNX | Crinetics Pharmaceuticals Inc | $51.38 | -0.53 | -1.02% | 21,855 | 4.05B | N/A | -3.78 | Gesundheitstechnologie | Führende Pharmazeutika |
| INSM | Insmed Inc | $24.76 | -0.34 | -1.35% | 67,463 | 3.68B | N/A | -5.23 | Gesundheitstechnologie | Führende Pharmazeutika |
| RARE | Ultragenyx Pharmaceutical Inc. | $41.91 | -0.70 | -1.64% | 29,697 | 3.48B | N/A | -8.03 | Gesundheitstechnologie | Führende Pharmazeutika |
| BHVN | Biohaven Ltd | $37.37 | -1.08 | -2.82% | 62,588 | 3.30B | N/A | -6.83 | Gesundheitstechnologie | Führende Pharmazeutika |
| PBH | Prestige Consumer Healthcare Inc | $64.68 | -0.30 | -0.46% | 14,636 | 3.23B | 15.44 | 4.17 | Gesundheitstechnologie | Führende Pharmazeutika |
| IDYA | Ideaya Biosciences Inc | $40.50 | -1.03 | -2.48% | 17,072 | 3.07B | N/A | -2.01 | Gesundheitstechnologie | Führende Pharmazeutika |
| XENE | Xenon Pharmaceuticals Inc | $39.78 | -0.56 | -1.39% | 8,022.00 | 3.00B | N/A | -2.71 | Gesundheitstechnologie | Führende Pharmazeutika |
| CORT | Corcept Therapeutics Inc | $28.12 | 0.58 | 2.11% | 32,738 | 2.93B | 25.98 | 1.06 | Gesundheitstechnologie | Führende Pharmazeutika |
| FOLD | Amicus Therapeutics Inc | $9.58 | 0.08 | 0.84% | 79,989 | 2.84B | N/A | -0.49 | Gesundheitstechnologie | Führende Pharmazeutika |
| TGTX | TG Therapeutics Inc | $16.49 | -0.93 | -5.34% | 138.40K | 2.55B | 75.74 | 0.23 | Gesundheitstechnologie | Führende Pharmazeutika |
| PTCT | PTC Therapeutics Inc | $33.11 | -0.92 | -2.70% | 19,920 | 2.54B | N/A | -7.68 | Gesundheitstechnologie | Führende Pharmazeutika |
| MLTX | MoonLake Immunotherapeutics - Class A | $39.70 | -1.16 | -2.84% | 13,626 | 2.61B | N/A | -0.75 | Gesundheitstechnologie | Führende Pharmazeutika |
| ACAD | Acadia Pharmaceuticals Inc | $14.78 | -0.07 | -0.47% | 69,337 | 2.44B | N/A | -0.01 | Gesundheitstechnologie | Führende Pharmazeutika |
| VCEL | Vericel Corp | $48.35 | 0.74 | 1.55% | 6,643.00 | 2.35B | N/A | -0.01 | Gesundheitstechnologie | Führende Pharmazeutika |
| INDV | Indivior Plc | $16.97 | -0.37 | -2.13% | 1,405.00 | 2.34B | 11.33 | 0.01 | Gesundheitstechnologie | Führende Pharmazeutika |
| AMPH | Amphastar Pharmaceuticals Inc | $43.52 | 0.78 | 1.82% | 9,651.00 | 2.13B | 12.57 | 2.89 | Gesundheitstechnologie | Führende Pharmazeutika |